
GenosAI, embedded into H1's clinical trial intelligence platform, Trial Landscape, can analyze and respond to complex inquiries.

GenosAI, embedded into H1's clinical trial intelligence platform, Trial Landscape, can analyze and respond to complex inquiries.

Developed with industry stakeholders, Longboat v2.2 provides patients with access to their study information in one site-focused solution.

Collaboration to focus on accelerating clinical development and increase access to research.

Company intends to expand AI and predictive clinical trial intelligence throughout the Asia-Pacific region.

New clinical research approach aims to accelerate and streamline clinical development for emerging biopharm organizations.

Company can now incorporate affiliates into safety workflows, boost operational efficiencies, ensure compliance, and unify its global pharmacovigilance data on one platform.

Ronco is a global pharmaceutical executive with experience in a number of R&D leadership positions over more than two decades.

Bingham discusses the logistical challenges associated with coordinating patient involvement in rare disease clinical trials.

Agency is announcing the opportunity for a limited number of sponsors to participate in a pilot program allowing for more frequent communication with FDA staff.

With support from LabCorp, partnership aims to bring trials to patients in south central Kentucky.

Strategic collaboration aims to drive diversity and inclusion within the realm of clinical trials.

Platform enables management of high-frequency sensor data with security.

Exploring the implications of FDA’s renewed focus and commitment to expand the use of accelerated approval for gene therapy products.

Joint venture aims to streamline handling of tissue and samples and subsequent digitization in support of clinical trial endpoint generation.

Scheduled visits can become virtual with video calls augmented directly through the platform and patients signing in through their existing participant portal.

Platform includes an expanded global library.

Legislative efforts seek a common framework in accessing and applying real-world data and evidence in clinical studies.

Company expected to research patient engagement, response durability, and health economics of new medical device.

Platform implements patient insights and data to help create diversity action plans.

New protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.

Steve Rosenberg, CEO, uMotif, discusses how patients would like to be involved in clinical trials as innovations in digital technologies continue to evolve.

Data quality co-pilot considered the first of its kind.

Updates provide comprehensive insights for tracking patient progression and analyzing clinical data, company says.

Clinic passed an evaluation process that involved inspection of its clinical laboratory facilities, equipment, processes, quality control measures, and personnel qualifications.

New solution provides biopharma and research organizations with tools for analyzing kidney structures and quantifying lesions that impact kidney health.

Tool offers a more holistic workflow, new data management automations, and integration of essential clinical trial documentation.

Panel at recent Talk Health event at Le Méridien, in Philadelphia, PA, on September 11th, 2023, focused on what success looks like in audio from a publisher, vendor, and HCP perspectives.

A 1-year observational follow-up of a 3-month RCT provides insight into he benefits of advanced hybrid closed-loop system use in people with type 1 diabetes using multiple daily injections and self-monitoring of blood glucose.

Solution designed to accelerate the process of matching patients with eligible clinical trials.